Latest Regulatory News

HITIQ Limited has drawn down a $1 million loan from a major shareholder associate, with plans to convert the debt into convertible notes subject to shareholder approval. The initial tranche aims to bolster working capital amid ongoing capital market challenges.

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

Kinatico Ltd has reported a 30% year-on-year rise in SaaS revenue to $5.2 million for Q3 FY26, with EBITDA up 27% amid extended sales cycles and economic uncertainty. The company’s AI-native compliance platform is well positioned for regulatory tailwinds starting July 2026.

Predictive Discovery and Robex Resources have completed all merger steps except the final administrative confirmation from Quebec, bringing the combined West African gold producer closer to operational integration.

Horizon Oil has crossed the crucial 50.1% acceptance threshold in its off-market bid for Cue Energy, removing a key condition from the offer. Meanwhile, the Mereenie joint venture suspends planned drilling after gas sales talks with Northern Territory’s Power and Water Corporation expire.

Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.

European Resources Limited has more than doubled the inferred resource at its Korsnäs rare earth elements project in Finland to 15.4 million tonnes at 1.00% total rare earth oxides, driven by new drilling, re-assaying of historical core, and a refined geological model.

Future Metals has unveiled a lower-risk, lower-capital pathway for its Panton PGM Project by leveraging the idle Savannah Plant, delivering upfront savings of around A$74 million and preserving long-term growth potential.

Bass Oil is set to ramp up Indonesian production by drilling the Bunian 6 well, targeting a tripling of output to 750 barrels per day by mid-2026 amid elevated oil prices.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.

American Uranium has completed a A$2.64 million placement by issuing 22 million shares at A$0.12 each, aiming to fund drilling and technical studies at its Wyoming uranium projects.